Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

NCT05121402 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decisions made by senior management of the company

Conditions

Ulcerative Colitis

Interventions

DRUG: TLL018
OTHER: Placebo

Sponsor

TLL Pharmaceutical, LLC